Cargando…
First-line therapies for Helicobacter pylori eradication: a critical reappraisal of updated guidelines
Helicobacter pylori (H. pylori) treatment remains a challenge for the clinician, as no available therapy is able to cure the infection in all treated patients. In the last two decades, several antibiotic combinations have been proposed, including triple therapies, bismuth-free therapies (sequential,...
Autores principales: | De Francesco, Vincenzo, Bellesia, Annamaria, Ridola, Lorenzo, Manta, Raffaele, Zullo, Angelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479989/ https://www.ncbi.nlm.nih.gov/pubmed/28655973 http://dx.doi.org/10.20524/aog.2017.0166 |
Ejemplares similares
-
High-dose esomeprazole and amoxicillin dual therapy for first-line Helicobacter pylori eradication: a proof of concept study
por: Zullo, Angelo, et al.
Publicado: (2015) -
First- and second-line Helicobacter pylori eradication with modified sequential therapy and modified levofloxacin-amoxicillin-based triple therapy
por: Zullo, Angelo, et al.
Publicado: (2014) -
Helicobacter pylori and portal hypertensive gastropathy: any new information?
por: Zullo, Angelo, et al.
Publicado: (2014) -
Newer agents for Helicobacter pylori eradication
por: Fiorini, Giulia, et al.
Publicado: (2012) -
Helicobacter pylori infection and gastroesophageal cancer: unveiling a Hamletic dilemma
por: Zullo, Angelo, et al.
Publicado: (2014)